Development
Zimmer Biomet Holdings, Inc.
ZBH
$92.38
$0.460.50%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 157.65% | -22.38% | -9.85% | 278.16% | -167.27% |
| Total Depreciation and Amortization | 0.00% | 1.56% | 2.46% | 1.44% | -1.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -546.84% | -53.67% | 49.56% | -91.05% | 342.36% |
| Change in Net Operating Assets | 98.29% | 38.41% | 25.70% | -65.19% | -237.27% |
| Cash from Operations | 74.29% | -2.96% | 13.06% | 26.00% | -45.83% |
| Capital Expenditure | 4.77% | 18.60% | -41.16% | 0.00% | -9.01% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | 25.93% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 236.09% | 63.50% | -4,530.00% | -105.88% | -49.40% |
| Cash from Investing | -33.19% | 31.84% | -62.72% | -32.80% | -32.04% |
| Total Debt Issued | 187.68% | -385.00% | -45.95% | -1.33% | 373.72% |
| Total Debt Repaid | -175.31% | 252.83% | 5.42% | 46.71% | -2,196.07% |
| Issuance of Common Stock | -6.76% | -17.53% | -30.28% | 141.61% | -18.13% |
| Repurchase of Common Stock | -- | 100.00% | 94.66% | -111.71% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.20% | 0.40% | 0.00% | 0.20% | -0.20% |
| Other Financing Activities | -212.50% | 67.35% | 66.44% | -1,985.71% | 63.16% |
| Cash from Financing | -28.27% | -79.16% | 47.07% | 34.05% | -61.63% |
| Foreign Exchange rate Adjustments | 305.56% | 37.93% | -300.00% | -75.83% | 194.49% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 546.57% | -166.35% | 77.14% | 73.19% | -206.73% |